Lifestyle & Wsparcie 2026 Nie zostawiamy badacza samego
GLIM criteria help identify malnutrition risk early, but the challenge is that GLP-1-induced anorexia can mask progressive muscle depletion behind improving metabolic markers
GLP-1 is accelerating that movement, compressing what might have been a gradual evolution into a more immediate change
Market perspective Fast-track approval reflects urgency in tackling obesity Oral therapies may capture ~20% of the market by 2030 Expands access for patients preferring pills over injections While Novo Nordisk may offer slightly higher weight loss with its oral option, ease of use and flexibility position this therapy as a strong competitor
Unlike traditional calorie-focused apps, MeAgain shifts the emphasis to protein, fiber, and water intake - key factors for maintaining muscle and managing gastrointestinal symptoms
Examples include cake, fruit pie, and frozen treats like ice cream, sherbet, and frozen yogurt